Back
MARRVEL-MCPHGNC PubMedLLM appliedClinical pipeline

MARRVEL-MCP: An agentic interface for Mendelian disease discovery via tool-augmented context engineering.

Everton Z, Botas J, Kim SY et al.Am J Hum Genet 2026 · June 2026
Relevance score
9/10
Disease / domain
Mendelian diseases — variant interpretation
Source
PubMed
PMID 42167217
Share on LinkedIn

Tool / method

LLM agentic interface integrating 44 genomic databases via tool-augmented context engineering

Summary

MARRVEL-MCP is a tool-augmented agentic interface that enables LLMs to query 44 genomic databases for variant interpretation in Mendelian diseases. On 100 expert-curated standardized questions, a 20B model coupled with MARRVEL-MCP achieves 94% correct answers versus 41% without the system. The platform reduces cognitive burden on specialists and makes variant interpretation accessible to non-experts. Code is available open-source.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

Context engineering via specialized tools rather than fine-tuning alone opens a pragmatic pathway: genomic databases evolve constantly, fine-tuned models age poorly, while an agentic interface remains current. Validation on 100 expert questions is promising but insufficient for clinical adoption without prospective evaluation on real cases.

Why this score?

Clinical impact: 3/3 · Evidence strength: 2/3 · Novelty: 2/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 9/10

Keywords

LLMMendelian diseasesvariant interpretationclinical AIMARRVELagentic tool
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime